A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

A scientific report has raised questions about how much Leqimbi and Kisunla — the “breakthrough” Alzheimer’s drugs that have ...

For many years, Alzheimer’s disease has been one of the biggest challenges in medicine. It slowly damages memory, thinking, ...

A major Cochrane review of clinical trials has found that anti-amyloid Alzheimer's drugs donanemab and lecanemab have minimal ...

Two Alzheimer's drugs were hailed as treatments that would transform care. Why are barely any UK patients getting them?

A recently-published report has raised fresh concerns regarding the inefficacy of “breakthrough” Alzheimer’s drugs. As per ...

Drugs once hailed as a breakthrough in the fight against Alzheimer's disease do not meaningfully help patients, a major ...

I have been following the story here of the newest Alzheimers drugs, the first to show that they can actually slow the ...

The EU’s drug regulator said it stands by its approval of two new Alzheimer’s drugs after a recent large-scale scientific ...

An analysis has found that anti-amyloid drugs, once hailed as a breakthrough in Alzheimer's treatment, have low clinical ...

Rumors about tech billionaire Bill Gates' supposed involvement in remedies for Alzheimer's disease or dementia circulated for ...